WELL Health Technologies

WELL Health Technologies Named As One Of The 2019 TSX Venture 50 Companies

WELL Health Technologies Named As One Of The 2019 TSX Venture 50 Companies

VANCOUVER, Feb. 25, 2019 /PRNewswire/ – WELL Health Technologies Corp. (TSXV: WELL) (“WELL” or the “Company”), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, is pleased to announce that it has been ranked 2nd in Diversified Industries on the 2019 TSX Venture 50.

https://www.tmxmoney.com/en/investor_tools/venture50.html

The 2019 TSX Venture 50 is a ranking of the top performers on the TSX Venture Exchange over the last year. The ranking is comprised of 10 companies from each of the five industry sectors, selected based on three equally weighted criteria which are market capitalization growth, share price appreciation, and trading volume amount.

“We are very honored to receive this recognition from the TSX Venture Exchange” said Hamed Shahbazi, CEO of WELL Health Technologies Corp. “The response to our vision for WELL has been very encouraging and we look forward to continuing our efforts to enhance shareholder value”.

About WELL Health Technologies Corp.

Backed by legendary investor and business magnate Sir Li Ka‐shing, WELL owns and operates Primary Healthcare Facilities and an Electronic Medical Record service provider in Canada.  WELL's overarching objective is to empower primary care doctors to provide the best and most advanced care possible while leveraging the latest trends in digital health.  WELL physicians serve approximately 600,000 patient visits per year through its network of 19 medical clinics.  WELL’s digital business provides EMR and EMR hosting services to more than 220 clinics, supporting more than 2,000 physicians and medical professionals, and 4.95M patients. WELL is publicly traded on the TSX Venture Exchange under the symbol WELL.V.  WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.

Forward-Looking Statements

This news release may contain “forward-looking statements” within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause future results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. WELL Health Technologies’ expressed or implied by these forward-looking statements are subject to a number of risks, uncertainties and conditions, many of which are outside of WELL Health Technologies Corp's control. For a description of the risks associated with WELL Health Technologies’ business please refer to the “Risk Factors” section of WELL Health Technologies’ annual information form dated March 6, 2018 which is available at www.sedar.com. Except as required by law, WELL Health Technologies disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise.

Contact:
Pouya Farmand
Pfarmand@gravitassecurities.com
(778) 867-4726

SOURCE: WELL HEALTH TECHNOLOGIES CORP.

up-white